Table 2 Diagnostic performance matrix.
Internal validation | ||||||
---|---|---|---|---|---|---|
Onefold | Actual positive | Actual negative | Twofold | Actual positive | Actual negative | |
0.5 of Cut-off Value | Predicted positive | 113 | 23 | Predicted positive | 112 | 31 |
Predicted negative | 20 (Type A 19/117, 16.3%; Type B 1/16, 6.2%) | 470 | Predicted negative | 21 (Type A 17/114, 14.9%; Type B 4/19, 11.1%) | 462 |
Internal validation | ||||||
---|---|---|---|---|---|---|
Threefold | Actual positive | Actual negative | Fourfold | Actual positive | Actual negative | |
0.5 of Cut-off Value | Predicted positive | 108 | 34 | Predicted positive | 119 | 38 |
Predicted negative | 24(Type A 21/105, 20.0%; Type B 3/27, 11.1%) | 459 | Predicted negative | 13 (Type A 10/111, 9.1%; Type B 3/21, 14.3%) | 455 |
Internal validation | Test | |||||
---|---|---|---|---|---|---|
Fivefold | Actual positive | Actual negative | Actual positive | Actual negative | ||
0.5 of Cut-off Value | Predicted positive | 117 | 38 | Predicted positive | 51 | 17 |
Predicted negative | 15 (Type A 14/109, 12.8%; Type B 1/23, 4.3%) | 455 | Predicted negative | 3 (Type A 0/31, 0.0%; Type B 3/23, 13.1%) | 133 |